Author name: systems

Across the world, rates of depression have reached alarming new heights as a result of the grief, uncertainty and isolation experienced through the pandemic. Despite the high prevalence of depression, its treatment remains a hit-or-miss affair. Up to two-thirds of patients fail to respond to the first antidepressant prescribed and many of them never return […]

Source/Disclosures Disclosures: Khanna reports receiving consulting fees from Edwards Lifesciences, Medtronic and Philips North America, and grant support from the NIH/National Center for Advancing Translational Sciences Wake Forest Clinical and Translational Science Institute for a randomized trial of continuous postoperative hemodynamic and respiratory monitoring. Please see the study for all other authors’

Wellness This edition of the Mayo Clinic Q&A podcast features an #AskMayoMom episode hosted by Dr. Angela Mattke, a pediatrician at Mayo Clinic Children’s Center. Joining Mattke to discuss teens and depression are Dr. Paige Partain, a Mayo Clinic pediatrician, and Hannah Mulholland, a Mayo Clinic pediatric social worker. Written By: Mayo Clinic News Network | 1:21 pm, May 7, 2021

Wellness This edition of the Mayo Clinic Q&A podcast features an #AskMayoMom episode hosted by Dr. Angela Mattke, a pediatrician at Mayo Clinic Children’s Center. Joining Mattke to discuss teens and depression are Dr. Paige Partain, a Mayo Clinic pediatrician, and Hannah Mulholland, a Mayo Clinic pediatric social worker. Written By: Mayo Clinic News Network | 1:21 pm, May 7, 2021

Wellness This edition of the Mayo Clinic Q&A podcast features an #AskMayoMom episode hosted by Dr. Angela Mattke, a pediatrician at Mayo Clinic Children’s Center. Joining Mattke to discuss teens and depression are Dr. Paige Partain, a Mayo Clinic pediatrician, and Hannah Mulholland, a Mayo Clinic pediatric social worker. Written By: Mayo Clinic News Network | 1:21 pm, May 7, 2021

Covid: Depression rises in young and women during second peak  BBC News

The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Applications (sNDAs) for lumateperone for the treatment of depressive episodes associated with bipolar I or II disorder, as monotherapy and as adjunctive therapy with lithium or valproate. The sNDA submissions are supported by data from 2 global randomized, double-blind, placebo-controlled phase

Relationships and depression can be linked. Sometimes, the relationship itself triggers someone’s depression. However, people can also experience depression even if their relationship is a happy one. People may use the term “relationship depression” to describe depression that develops due to relationship difficulties. However, this is not a distinct medical condition. This article will look

Since the early 1990s, I, together with my colleagues, have been studying the economic burden of adults with major depressive disorders (MDD). Over that time, we have tracked shifts in the prevalence of this disease; in the makeup of those suffering from it; and in the nature of treatment both for the disease itself and